छोड़कर सामग्री पर जाएँ

Concord Biotech IPO final day | Investors buy 6.83 times, retail portion booked 3 times

Concord Biotech IPO | The main objective of the issue is to give a exit to Helix Investment Holdings which has 20 percent stake in the company.

Top 100 Best Sellers

Read More

​ Concord Biotech IPO | The main objective of the issue is to give a exit to Helix Investment Holdings which has 20 percent stake in the company. Concord Biotech IPO | The main objective of the issue is to give a exit to Helix Investment Holdings which has 20 percent stake in the company.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी
en_USEnglish hi_INहिन्दी